REFERENCES
- National Institute for Health and Clinical Excellence. NICE clinical guidelines: CG 62: Antenatal Care. Issued March 2008; last modified June 2010. http://publications.nice.org.0k/antenatal-care-cg62/guidance#provision-and-organisation-of-care. Accessed March 13, 2013.
- Sistema nazionale per le Linee Guida. Gravidanza fisi-ologica. Linea Guida 20. November 2010; revised Septem-ber 2011. http://www.salute.gov.it/imgs/c_17_pubblica-zioni_1436_allegato.pdf. Accessed March 13, 2013.
- Florey CD, Taylor DJ. The relation between antenatal care and birth weight. Rev Epidemiol Sante Publique. 1994;42:191–197.
- Raatikainen K, Heiskanen N, Heinonen S. Under-attending free antenatal care is associated with adverse pregnancy outcomes. BMC Public Health. 2007;7:268.
- Okunlola MA, Owonikoko KM, Fawole AO, Adekunle AO. Gestational age at antenatal booking and delivery out-come. Afr J Med Med Scl. 2008;37:165–169.
- Stacey T, Thompson JM, Mitchell EA, Zuccollo JM, Ekeroma AJ, McCowan LM. Antenatal care, identification of suboptimal fetal growth and risk of late stillbirth: Find-ings from the Auckland Stillbirth Study. Aust N Z J Obstet Gynaecol. 2012;52:242–247.
- Baker EC, Rajasingam D. Using Trust databases to identify predictors of late booking for antenatal care within the UK. Public Health. 2012;126:112–116.
- Rowe RE, Magee H, Quigley MA, Heron P, Askham J, Brocklehurst P. Social and ethnic differences in atten-dance for antenatal care in England. Public Health. 2008;122:1363–1372.
- Beeckman K, Louckx F, Putman K. Predisposing, enabling and pregnancy-related determinants of late initiation of prenatal care. Matem Child Health J. 2011;15:1067–1075.
- Enabudoso EJ, Obhielo E. Socio-demographic and obstetric determinants of gestational age at booking at the University of Benin Teaching Hospital: A descriptive survey. Niger Postgrad Med J. 2012;19:149–152.
- Basu JK, Basu D, Jeketera CM. Demographic and clinical variables influencing gestational age at booking among South African pregnant women. J Obstet Gynaecol. 201131: 718–720.
- Adekanle DA, Isawumi Al. Late antenatal care booking and its predictors among pregnant women in south western Nigeria. Online J Health Allied Scs. 2008;7:1–4.
- Ebeigbe PN, Igberase GO. Reasons given by pregnant women for late initiation of antenatal care in the Niger Delta, Nigeria. Ghana Med J. 2010;44:47–51.
- Ebeigbe PN, Igberase GO. Antenatal care: A comparison of demographic and obstetric characteristics of early and late attenders in the Niger Delta, Nigeria. Med Sci Monit. 2005;11:CR529–32.
- Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. http://aidsinfo.nih.gov/ContentFiles/PerinataIGL.pdf. Accessed March 17, 2014.
- EACS. European AIDS Clinical Society guidelines. Version 7.0. October 2013. http://http://www.eacsociety.org/Por-tals/0/Guidelines_Online_131014.pdf. Accessed March 17,2014.
- Antinori A, Marcotullio S, Ammassari A, et al. Italian guide-lines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011. New Microbiol. 2012;35(2)113–159.
- Jasseron C, Mandelbrot L, Tubiana R, et al. Prevention of mother-to-child HIV transmission: Similar access for sub-Sahara African immigrants and for French women ? AIDS. 2008;22:1503–1511.
- Tariq S, Elford J, Cortina-Borja M, Tookey PA; National Study of HIV in Pregnancy and Childhood. The associa-tion between ethnicity and late presentation to antenatal care among pregnant women living with HIV in the UK and Ireland. AIDS Care. 2012;24:978–985.
- Girardi E, Vanacore P, Costa F, et al. Trends in HIV preva-lence among pregnant women in Italy, 1994 to 2002. J Acquir Immune Defic Syndr. 2006; 41:361–364.
- Scheuerle A, Tilson H. Birth defect classification by organ system: A novel approach to heighten teratogenic signal-ling in a pregnancy registry. Pharmacoepidemiol Drug Saf. 2002;11:465–475.
- Bertino E, Spada E, Occhi L, et al. Neonatal anthropo-metric charts: The Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr. 2010;51:353–361.
- Tomasoni LR, Sosta E, Beltrame A, et al. Antenatal screening for mother to child infections in immigrants and residents: The case of toxoplasmosis in northern Italy. J Immigr Minor Health. 2010;12:834–840.
- Khalil A, Rezende J, Akolekar R, Syngelaki A, Nico-!aides KH. Maternal racial origin and adverse pregnancy outcome: A cohort study. Ultrasound Obstet Gynecol. 2013;41:278–285.
- European Collaborative Study. The mother-to-child HIV transmission epidemic in Europe: Evolving in the East and established in the West. AIDS. 2006;20:1419–1427.
- Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA. Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990-2006. BJOG. 2008;115:1078–1086.
- European Collaborative Study. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: Changing practices in Western Europe. HIV Med. 2010;11:368–378.
- Floridia M, Tamburrini E, Anzidei G, et al. Declining HCV seroprevalence among pregnant women with HIV. Epide-miol Inf. 2010;138:1317–1321.
- Solarin I, Black V. “They told me to come back”: Women’s antenatal care booking experience in inner-city Johannes-burg. Matem Child Health J. 2013;17:359–367.
- Ravizza M, Martinelli P, Bucceri A, et al. Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women. J Infect Dis. 2007;195:913–914.
- Powis KM, Kitch D, Ogwu A, et al. Increased risk of preterm delivery among HIV-infected women random-ized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. J Infect Dis. 2011204: 506–514.
- Sibiude J, Warszawski J, Tubiana R, et al. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: Role of the ritonavir boost ? Clin Infect Dis. 2012;54:1348–1360.
- Watts DH, Williams PL, Kacanek D, et al. Combina-tion antiretroviral use and preterm birth. J Infect Dis. 2013;207:612–621.
- European Collaborative Study in EuroCoord, Bailey H, Townsend C, Cortina-Borja M, Thorne C. Insuffi-cient antiretroviral therapy in pregnancy: Missed opportu-nities for prevention of mother-to-child transmission of HIV in Europe. Antivir Ther. 201116: 895–903.
- Read PJ, Mandalia S, Khan P, et al. When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery ?AIDS. 2012;26:1095–1103.
- Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry international interim report for 1 Jan 1989–31 July 2013. Wilmington, NC: Reg-istry Coordinating Center; 2012. http://www.apregistry.com/forms/exec-summary.pdf. Accessed March 17,2014.
- Aebi-Popp K, Mulcahy F, Glass TR, et al. Missed opportu-nities among HIV-positive women to control viral replica-tion during pregnancy and to have a vaginal delivery. J Acquir Immune Defic Syndr. 2013;64:58–65.